Navigating ER+ HER2- Early Breast Cancer
We are thrilled to announce the first webinar in our new series, "Navigating ER+ HER2- Early Breast Cancer," taking place on November 19, 2024 , at 6:00 PM CET! This series will explore the latest strategies and cutting-edge developments in the treatment and management of early breast cancer.
Join us for the inaugural session, where we will focus on CDK4/6 inhibitors in the adjuvant setting for clinically high-risk breast cancer patients. Our expert speakers, Prof. Michael Untch from Helios Clinic Berlin Buch, Germany, and Prof. Frederique Penault-Llorca from the CLCC Jean Perrin de Clermont Ferrand, France, will lead insightful discussions, present actual prospective data and discuss case studies.
Register now! SECURE YOUR SPOT!
Don’t miss out on this opportunity to learn from experts and participate in case-based discussions!
We look forward to seeing you there!